COMMUNIQUÉ DE PRESSE publié le 29/10/2025 à 09:45, il y a 7 mois 29 jours Evotec SE to announce results for the first nine months 2025 on 05 November 2025 Evotec SE to announce results for the first nine months 2025 on 05 November 2025. The Company will hold a conference call in English to discuss the interim statement Conference Call Financial Report Evotec SE Results Interim Statement
BRÈVE publiée le 27/10/2025 à 07:35, il y a 8 mois Evotec progresse dans le partenariat en neurosciences avec Bristol Myers Squibb Partenariat Neuroscience Evotec Bristol Myers Squibb Neurodégénératif
BRÈVE publiée le 27/10/2025 à 07:35, il y a 8 mois Evotec Advances in Neuroscience Partnership with Bristol Myers Squibb Partnership Neuroscience Evotec Bristol Myers Squibb Neurodegenerative
COMMUNIQUÉ DE PRESSE publié le 27/10/2025 à 07:30, il y a 8 mois Evotec announces progress in preclinical neuroscience partnership with Bristol Myers Squibb Evotec SE announces US$ 25 m payment from Bristol Myers Squibb for progress in preclinical neuroscience partnership, advancing research on neurodegenerative diseases Partnership Evotec SE Neurodegenerative Diseases Bristol Myers Squibb Research Progress
BRÈVE publiée le 13/08/2025 à 07:05, il y a 10 mois 14 jours Evotec SE Reports H1 2025 Results Highlighting Strategic Progress Financial Performance Evotec SE Strategic Growth Biologics Development H1 2025 Results
BRÈVE publiée le 13/08/2025 à 07:05, il y a 10 mois 14 jours Evotec SE publie ses résultats du premier semestre 2025, soulignant les progrès stratégiques Evotec SE Performance Financière Croissance Stratégique Développement De Produits Biologiques Résultats Du Premier Semestre 2025
COMMUNIQUÉ DE PRESSE publié le 13/08/2025 à 07:00, il y a 10 mois 14 jours Evotec SE reports H1 2025 results: Strong progress on strategy execution Evotec SE reports strong progress on strategy execution with H1 2025 results, showcasing sustainable profitable growth and key collaborations with BMS and Sandoz Evotec SE Growth Collaborations Strategy Execution H1 2025 Results
BRÈVE publiée le 06/08/2025 à 09:57, il y a 10 mois 21 jours Evotec SE to Release First Half-Year Results 2025 Conference Call Drug Discovery Life Sciences Evotec SE Half-year Results
BRÈVE publiée le 06/08/2025 à 09:57, il y a 10 mois 21 jours Evotec SE publiera ses résultats du premier semestre 2025 Résultats Semestriels Evotec SE Conférence Téléphonique Sciences De La Vie Découverte De Médicaments
COMMUNIQUÉ DE PRESSE publié le 06/08/2025 à 09:52, il y a 10 mois 21 jours Evotec SE to announce first half-year results 2025 on 13 August 2025 Evotec SE to announce first half-year results for 2025 on 13 August 2025 with a conference call to discuss performance. Company focuses on drug discovery and development Conference Call Drug Discovery Evotec SE Half-year Results AI-driven Innovation
Publié le 27/06/2026 à 16:50, il y a 2 heures 26 minutes Redwood AI Announces Definitive Agreement with Quantum.IQ and Expands into Quantum Resistant Cyber Security
Publié le 27/06/2026 à 01:40, il y a 17 heures 36 minutes Polaris Renewable Energy Announces Results of Director Elections at Annual and Special Meeting
Publié le 27/06/2026 à 00:00, il y a 19 heures 16 minutes Onco-Innovations Initiates Three-Species Hepatocyte and Microsome Metabolism Studies for ONC010
Publié le 26/06/2026 à 23:00, il y a 20 heures 16 minutes Canadian North Resources Inc. Announces Results of 2026 Annual General and Special Shareholders Meeting
Publié le 26/06/2026 à 22:50, il y a 20 heures 26 minutes Banyan Gold Files Technical Report for AurMac Project, Yukon, Canada
Publié le 27/06/2026 à 00:05, il y a 19 heures 10 minutes EAN Congress: Hearing aid use linked to 23% lower dementia risk in people with both epilepsy and hearing loss
Publié le 27/06/2026 à 00:04, il y a 19 heures 11 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent - Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 19 heures 40 minutes Persistent and Nagarro sign Business Combination Agreement to form the Persistent – Nagarro Group, a global leader in AI-led digital engineering
Publié le 26/06/2026 à 23:36, il y a 19 heures 40 minutes EQS-Adhoc: Nagarro SE: Nagarro signs business combination agreement with Persistent Systems and supports voluntary public takeover offer to all shareholders at EUR 81 per share
Publié le 26/06/2026 à 23:27, il y a 19 heures 48 minutes EQS-WpÜG: Takeover Offer / Target company: Nagarro SE; Bidder: Galaxy Germany Holding SE
